Todd Fehniger

37PUBLICATIONS
212CO-AUTHORS
Predictive and prognostic markersInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (37)

|Jul 10, 2026
Automating neoantigen selection for personalized cancer vaccine design.

|Jun 18, 2026
Inducible T-bet deletion reveals tissue-specific requirements in NKp46+ ILC immunobiology and response to murine cytomegalovirus.

|Mar 25, 2026
NT-I7, a Long-Acting Interleukin 7, Increases Lymphocyte Counts and Induces CD8+ T-cell Clonotype Expansion in Patients with Newly Diagnosed High-Grade Gliomas.

Omar H Butt, Kartik Singhal, Jingqin Luo

|Mar 12, 2025
Memory-like NK cell differentiation, inhibitory NKG2A blockade, and improved recognition via antibody or CAR engineering combine to enhance NK cell attack against multiple myeloma.

Alice Y Zhou, Nancy D Marin, Sadia Afrin

|Jan 30, 2025
Stroma-derived Dickkopf-1 contributes to the suppression of NK cell cytotoxicity in breast cancer.

Seunghyun Lee, Biancamaria Ricci, Jennifer Tran

|Jan 23, 2025
First-in-Human Phase I Study of a CD16A Bispecific Innate Cell Engager, AFM24, Targeting EGFR-Expressing Solid Tumors.

Anthony El-Khoueiry, Omar Saavedra, Jacob Thomas

Pageof 7

Frequent Collaborators

13 joint publications

Obi L Griffith

12 joint publications

Melissa M Berrien-Elliott

10 joint publications

Malachi Griffith

9 joint publications

Jennifer A Foltz